These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis. Nateghi-Rostami M; Sohrabi Y Front Immunol; 2024; 15():1304696. PubMed ID: 38469319 [TBL] [Abstract][Full Text] [Related]
8. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice. Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672 [TBL] [Abstract][Full Text] [Related]
9. Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Seyed N; Peters NC; Rafati S Front Immunol; 2018; 9():1227. PubMed ID: 29922288 [TBL] [Abstract][Full Text] [Related]
19. Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection. Glennie ND; Yeramilli VA; Beiting DP; Volk SW; Weaver CT; Scott P J Exp Med; 2015 Aug; 212(9):1405-14. PubMed ID: 26216123 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Leishmanization Using Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F Front Immunol; 2020; 11():1725. PubMed ID: 33193290 [No Abstract] [Full Text] [Related] [Next] [New Search]